ArticleBlood2010

Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.

Rosa Lapalombella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.